These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11454425)

  • 21. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.
    Heinrich MC; Rubin BP; Longley BJ; Fletcher JA
    Hum Pathol; 2002 May; 33(5):484-95. PubMed ID: 12094373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
    Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
    Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.
    Corless CL; McGreevey L; Haley A; Town A; Heinrich MC
    Am J Pathol; 2002 May; 160(5):1567-72. PubMed ID: 12000708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors.
    Matyakhina L; Bei TA; McWhinney SR; Pasini B; Cameron S; Gunawan B; Stergiopoulos SG; Boikos S; Muchow M; Dutra A; Pak E; Campo E; Cid MC; Gomez F; Gaillard RC; Assie G; Füzesi L; Baysal BE; Eng C; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2938-43. PubMed ID: 17535989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors).
    Breiner JA; Meis-Kindblom J; Kindblom LG; McComb E; Liu J; Nelson M; Bridge JA
    Cancer Genet Cytogenet; 2000 Jul; 120(2):111-6. PubMed ID: 10942800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
    Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
    Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal stromal tumours.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
    Lux ML; Rubin BP; Biase TL; Chen CJ; Maclure T; Demetri G; Xiao S; Singer S; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Mar; 156(3):791-5. PubMed ID: 10702394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.
    Andersson J; Sjögren H; Meis-Kindblom JM; Stenman G; Aman P; Kindblom LG
    Am J Pathol; 2002 Jan; 160(1):15-22. PubMed ID: 11786393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors.
    el-Rifai W; Sarlomo-Rikala M; Miettinen M; Knuutila S; Andersson LC
    Cancer Res; 1996 Jul; 56(14):3230-3. PubMed ID: 8764113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
    Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
    Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
    Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
    Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
    Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
    Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.